Artemisinin
CAS 63968-64-9
Artemisinin (CAS 63968-64-9) is a Phase 3 pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 6753.758563311688 nM | 615 | - |
| - | IC50 | 2.718979586538462 ug.mL-1 | 208 | - |
| - | EC50 | 3839.3454117647057 nM | 85 | - |
| - | AC50 | 29354.83870967742 nM | 31 | - |
| - | MIC | 57.95057894736842 ug.mL-1 | 19 | - |
| - | Potency | 8481.441176470587 nM | 17 | - |
| - | EC50 | 0.00795 ug.mL-1 | 4 | - |
| - | IC50 | 0.01125 uM well-1 | 4 | - |
| - | Ki | 8919.75 nM | 4 | - |
| - | GI50 | 11333.333333333334 nM | 3 | - |
| - | Kd | 340 nM | 2 | - |
| - | IC50 | 0.66 equiv | 1 | - |
| - | IC50 | 0.001 mg/cm3 | 1 | - |
| - | Kd | 0.000024 | 1 | - |
| Cytochrome P450 1A2 Enzyme |
IC50 | 5.699 | - | Homo sapiens |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| - | - | 8.149999618530273 pIC50 | 22363211 |
| - | - | 7.820000171661377 pIC50 | 22363211 |
| - | - | 8.520000457763672 pIC50 | 22363211 |
| - | - | 9.100000381469727 pIC50 | 22363211 |
| - | - | 8.239999771118164 pIC50 | 22363211 |
| - | - | 9.220000267028809 pIC50 | 22363211 |
| - | - | 8.270000457763672 pIC50 | 22363211 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Artemisinin used for in pharmaceutical contexts?
Artemisinin (CAS 63968-64-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Artemisinin?
No adverse-event association or SIDER side-effect rows are rendered for Artemisinin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Artemisinin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Artemisinin with EU status "permitted".
What clinical phase is Artemisinin in?
Artemisinin is rendered with ChEMBL max phase 3.
What bioactivity targets are documented for Artemisinin?
Artemisinin has 15 bioactivity rows in this page query. Rendered target entries include Cytochrome P450 1A2.